Koyfin Home > Directory > Health Care > Intercept Pharmaceuticals > Total Equity

Intercept Pharmaceuticals Total Equity Chart (ICPT)

Intercept Pharmaceuticals annual/quarterly Total Equity from 2011 to 2020.
  • Intercept Pharmaceuticals Total Equity for the quarter ending June 06, 2020 was $-79m a 265.92% decrease of -210m year over year
  • Intercept Pharmaceuticals Total Equity for the last 12 months ending June 06, 2020 was $-79m a 265.92% decrease of -210m year over year
  • Intercept Pharmaceuticals Annual Total Equity for 2019 was $52m a 62.89% increase of 32m from 2018
  • Intercept Pharmaceuticals Annual Total Equity for 2018 was $19m a 14.34% increase of 3m from 2017
  • Intercept Pharmaceuticals Annual Total Equity for 2017 was $16m a -1,821.96% decrease of -299m from 2016
Other Balance Sheet Metrics:
  • Intercept Pharmaceuticals Total Assets for the quarter ending September 09, 2018 was $557m a 13.04% increase of 73m year over year
  • Intercept Pharmaceuticals Other Liabilities for the quarter ending September 09, 2018 was $5m a -50.16% decrease of -3m year over year
View Chart On Koyfin

Quarterly ICPT Total Equity Data

06/2020$-79m
03/2020$-35m
12/2019$52m
09/2019$131m
06/2019$175m
03/2019$-55m
12/2018$19m
09/2018$96m
06/2018$147m
03/2018$-52m

Annual ICPT Total Equity Data

2019$52m
2018$19m
2017$16m
2016$315m
2015$602m
2014$231m
2013$82m
2012$66m
2011$-3m
2010$8m